Search

Your search keyword '"Bair, Tami L"' showing total 755 results
Start Over Author "Bair, Tami L"
755 results on '"Bair, Tami L"'

22. Abstract 12122: Five-Year Serial Measurement of the Intermountain Mortality Risk Score for Population Health Assessment Reveals Personalized Temporal Trajectories of Differential Longevity Over Two Decades

Author

Horne, Benjamin D, Bledsoe, Joseph R, Muhlestein, Joseph B, Woller, Scott C, Knowlton, Kirk U, Majercik, Sarah, Bair, Tami L, Snow, Gregory L, Lloyd, James F, Le, Viet T, Bennett, Sterling T, Ronnow, Brianna S, May, Heidi T, and Anderson, Jeffrey L

Published
2022
Full Text
View/download PDF

28. Coronary Calcium Is Elevated in Patients with Myocardial Infarction without Standard Modifiable Risk Factors.

Author

Anderson, Jeffrey L., Knight, Stacey, Dong, Li, May, Heidi T., Le, Viet T., Bair, Tami L., and Knowlton, Kirk U.

Subjects
MYOCARDIAL infarction, CORONARY artery calcification, MAJOR adverse cardiovascular events
Abstract

Objectives: Recent reports have highlighted myocardial infarction (MI) patients without standard modifiable risk factors (SMRF), noting them to be surprisingly common and to have a substantial risk of adverse outcomes. The objective of this study was to address the challenge of identifying at-risk patients without SMRF and providing preventive therapy. Methods: Patients presenting between 2001 and 2021 to Intermountain Health catheterization laboratories with a diagnosis of MI were included if they also had a coronary artery calcium (CAC) scan by computed tomography within 2 years. SMRF were defined as a clinical diagnosis or treatment of hypertension, hyperlipidemia, diabetes, or smoking. The co-primary endpoints in SMRF-less patients were: (1) proportion of patients with an elevated (>50%ile) CAC score, and (2) an indication for statin therapy (i.e., CAC ≥ 100 AU or ≥75%ile). The 60-day and long-term major adverse cardiovascular events were determined. A comparison set included MI patients with SMRF. Results: We identified 429 MI patients with a concurrent CAC scan, of which 60 had no SMRF. SMRF status did not distinguish most risk factors or interventions. No-SMRF patients had a high CAC prevalence and percentile (82% ≥ 50%ile; median, 80%ile), and 77% met criteria for preventive therapy. As expected, patients with SMRF had high CAC scores and percentiles. Outcomes were more favorable for No-SMRF status and for lower CAC scores. Conclusions: Patients without SMRF presenting with an MI have a high prevalence and percentile of CAC. Wider application of CAC scans, including in those without SMRF, is promising as a method to identify an additional at-risk population for MI and to provide primary preventive therapy. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

34. Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular events

Author

Le, Viet T., primary, Knight, Stacey, additional, Watrous, Jeramie D., additional, Najhawan, Mahan, additional, Dao, Khoi, additional, McCubrey, Raymond O., additional, Bair, Tami L., additional, Horne, Benjamin D., additional, May, Heidi T., additional, Muhlestein, Joseph B., additional, Nelson, John R., additional, Carlquist, John F., additional, Knowlton, Kirk U., additional, Jain, Mohit, additional, and Anderson, Jeffrey L., additional

Published
2023
Full Text
View/download PDF

36. A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: the apolipoprotein A1 remnant ratio (Apo A1/ [VLDL3+IDL])

Author

May, Heidi T, Nelson, John R, Kulkarni, Krishnaji R, Anderson, Jeffrey L, Horne, Benjamin D, Bair, Tami L, and Muhlestein, Joseph B

Abstract

Abstract Background Women often lag behind men in their risk of cardiovascular events. However, with age and the onset of menopause, women’s cardiovascular risk eventually becomes similar to that of men. This change in risk may, in part, be attributable to a shift to a more atherogenic lipid profile. Our objective was to evaluate standard- and sub-lipid parameters and the apo A1 remnant ratio: (apo A1/[VLDL3-C+IDL-C]) for their associations with death/myocardial infarction among peri- and post-menopausal women. Methods Women (N=711) >50 years of age undergoing coronary angiography were evaluated. Baseline clinical and angiographic characteristics, lipids, and sub-lipid levels (Vertical Auto Profile method) were collected. Cox regression analysis, adjusted by standard cardiovascular risk factors, was utilized to determine associations of lipid and sub-lipid tertiles(T) with death/myocardial infarction at 1 and 3 years. Results Patients averaged 67.7±9.4 years and 53.6% had underlying severe (≥70% stenosis) coronary artery disease. The apo A1 remnant ratio was found to have stronger associations for 1 year (T1 vs. T3: HR=2.13, p=0.03, T2 vs. T3: HR=1.57, p=0.21) and 3 year (T1 vs. T3: HR=2.32, p=0.002, T2 vs. T3: HR=1.97, p=0.01) death/myocardial infarction than any individual lipid (LDL-C, HDL-C, triglycerides, non-HDL-C) or sub-lipid (apo A1, apo B, VLDL3-C+IDL-C) measure, or any other well-known ratio (triglyercies/HDL-C, apo B/A1, TChol/HDL-C, HDL-C/[VLDL3-C+IDL-C]). Conclusions The apo A1 remnant ratio was a significant predictor of short and intermediate-term death/myocardial infarction risk among women >50 years of age. Furthermore, this ratio was found to have greater predictive ability than traditional lipid and sub-lipid parameters and represents a potential new risk marker.

Published
2013

38. PO-02-171 CLINICAL, HEALTHCARE UTILIZATION AND ECONOMIC IMPACT OF SAME DAY DISCHARGE FOLLOWING ATRIAL FIBRILLATION ABLATION

Author

Cutler, Michael J., primary, May, Heidi T., additional, Dong, Lydia, additional, Bair, Tami L., additional, Chapman, Jenny, additional, Melman, Yonathan F., additional, Crandall, Brian G., additional, Orme, Joseph, additional, Wang, David C., additional, Miller, Jared D., additional, Dan, Dan, additional, Burkart, Thomas, additional, Luni, Faraz, additional, Cooley, Ryan L., additional, Wood, Brent, additional, Buckway, Jason, additional, and Petersen, Sheralee, additional

Published
2023
Full Text
View/download PDF

48. Abstract 13128: Development and Initial Utilization of a Multi-institutional Distributed Data Network Designed to Evaluate Real-world Clinical Outcomes in Patients Presenting for Percutaneous Coronary Intervention (PCI): Results From the Building the Unique Device Identifier (UDI) Into Longitudinal Data for Medical Device Evaluation (BUILD) Network

Author

Muhlestein, Joseph B, Graham, Jove, Tcheng, James, McKinnon, Andrew, Knight, Stacey, May, Heidi T, Bair, Tami L, and Drozda, Joseph P

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results